Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (8)

2023

  1. Long Non-Coding RNA Signatures in the Ileum and Colon of Crohn’s Disease Patients and Effect of Anti-TNF-α Treatment on Their Modulation

    International Journal of Molecular Sciences, Vol. 24, Núm. 21

2021

  1. Biological Treatments in Inflammatory Bowel Disease: A Complex Mix of Mechanisms and Actions

    Biologics, Vol. 1, Núm. 2, pp. 189-210

  2. Gut microbiota and dietary factors as modulators of the mucus layer in inflammatory bowel disease

    International Journal of Molecular Sciences, Vol. 22, Núm. 19

  3. Profiling of Human Circulating Dendritic Cells and Monocyte Subsets Discriminates between Type and Mucosal Status in Patients with Inflammatory Bowel Disease

    Inflammatory Bowel Diseases, Vol. 27, Núm. 2, pp. 268-274

2020

  1. Serum adipokines as non-invasive biomarkers in Crohn’s disease

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial

    Therapeutic Advances in Gastroenterology, Vol. 12

  2. Immunomodulatory effect of gut microbiota-derived bioactive peptides on human immune system from healthy controls and patients with inflammatory bowel disease

    Nutrients, Vol. 11, Núm. 11

2018

  1. Human intestinal pro-inflammatory CD11chighCCR2+CX3CR1+ macrophages, but not their tolerogenic CD11c-CCR2-CX3CR1- counterparts, are expanded in inflammatory bowel disease article

    Mucosal Immunology, Vol. 11, Núm. 4, pp. 1114-1126